New
Image

20.08.2025
We welcome new NICE plans to widen access to newer type 2 diabetes med...
We welcome long-awaited draft guidance from the National Institute of Health and Care Excellence (NICE) t...
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.
Read more